2025-05-29 - Analysis Report
Okay, here's the analysis of Merck & Co Inc (MRK), incorporating the data you provided.

**Report on Merck & Co Inc (MRK)**

**0. Overview**

This report analyzes the performance of Merck & Co Inc (MRK) relative to the S&P 500 (VOO), considering various financial metrics, recent news, and technical indicators.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** MRK
*   **Company Description:** Merck & Co Inc is a global pharmaceutical company focused on healthcare solutions.
*   **MRK Cumulative Return:** -2.26%
*   **VOO Cumulative Return:** 82.09%
*   **Absolute Deviation:** -84.35%
*   **Relative Deviation:** 0.7% (The current deviation is near the lowest end of its historical range compared to VOO.)

**Alpha, Beta Analysis**

| Year       | CAGR     | MDD      | Alpha    | Beta   | Cap(B)  |
| ---------- | -------- | -------- | -------- | ------ | ------- |
| 2015-2017  | 5.0%     | 58.4%    | -24.0%   | 0.0    | 108.3   |
| 2016-2018  | 42.0%    | 66.6%    | 24.0%    | 0.1    | 151.6   |
| 2017-2019  | 40.0%    | 66.6%    | 11.0%    | 0.2    | 185.4   |
| 2018-2020  | 19.0%    | 66.6%    | -6.0%    | 0.4    | 172.0   |
| 2019-2021  | -1.0%    | 65.6%    | -55.0%   | 0.5    | 175.1   |
| 2020-2022  | 13.0%    | 69.3%    | 7.0%     | 0.5    | 261.6   |
| 2021-2023  | 35.0%    | 69.3%    | 19.0%    | 0.3    | 264.2   |
| 2022-2024  | -6.0%    | 69.3%    | -23.0%   | 0.3    | 247.7   |
| 2023-2025  | -55.0%   | 70.3%    | -85.0%   | 0.3    | 191.3   |

**Analysis:**

*   **Underperformance:** MRK has significantly underperformed the S&P 500 based on cumulative returns. The large negative deviation (-84.35%) indicates a substantial difference in performance.
*   **Relative Deviation Context:** A relative deviation of 0.7% suggests that this underperformance is near the extreme end of its historical range versus VOO.
*   **Alpha/Beta Trends:** Beta values are generally low, indicating low systematic risk exposure. Alpha values fluctuate, reflecting periods of both outperformance and underperformance relative to its risk-adjusted expected return. The recent years (2023-2025) show a significant negative alpha.
*   **Capitalization:** Market cap decreased significantly from 2021-2023 to 2023-2025 period, may require further analysis to understand reasons for decline

**2. Recent Stock Price Movement**

*   **Current Price:** $76.17
*   **Previous Close:** $77.59
*   **Price Change:** -$1.83
*   **5-Day Moving Average:** 77.23
*   **20-Day Moving Average:** 78.45
*   **60-Day Moving Average:** 83.89

**Analysis:**

*   **Downward Trend:** The stock price is below its 5, 20, and 60-day moving averages, indicating a short-term downward trend.
*   **Recent Drop:** The price change of -$1.83 from the previous close suggests recent selling pressure.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.37 (Low Risk)
*   **RSI:** 43.48 (Neutral)
*   **PPO:** 0.24
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (2 shares - Caution - MRI:0.37)
*   **Delta_Previous_Relative_Divergence:** -0.4 (Negative change indicates a recent short-term decline in relative performance.)
*   **Expected Return:** -1112.1% (This is a very negative projected return over a 2-year period compared to the S&P 500. This metric might be an anomaly, but should be investigated. High negative is a red flag!)

**Analysis:**

*   **MRI:** The MRI suggests a low-risk environment for the market.
*   **RSI:** An RSI of 43.48 indicates a neutral condition, neither overbought nor oversold.
*   **Hybrid Signal:** Despite the low MRI, the hybrid signal recommends a cautious approach.
*   **Recent Price Action:** The drop in price relative to the previous close signals a potentially concerning short-term issue that deserves attention.

**4. Recent News & Significant Events**

*   **[2025-05-25]:** Major business developments, regulatory changes, or market events impacting MRK.
*   **[2025-05-28]:** Analyst discussions on MRK's performance and outlook in relation to industry trends and economic factors.
*   **[2025-05-26]:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **[2025-05-27]:** Market experts highlighting both risks and opportunities, advising investors to monitor news and announcements.

**Analysis:**

*   **Active News Flow:** The frequent news indicates that MRK is experiencing significant activity.
*   **Volatility:** Mention of volatility suggests that the stock price may be subject to large swings based on these events.

**5. Recent Earnings Analysis**

| Date       | EPS  | Revenue     |
| ---------- | ---- | ----------- |
| 2025-05-02 | 2.01 | $15.53B     |
| 2024-11-06 | 1.25 | $16.66B     |
| 2024-08-05 | 2.15 | $16.11B     |
| 2024-05-03 | 1.88 | $15.78B     |
| 2025-05-02 | 1.88 | $15.78B     |

**Analysis:**

*   **Inconsistency:** There are two entries for "2025-05-02" with different EPS values, which needs clarification.
*   **Revenue Trend:** Revenue has been somewhat variable over the past few quarters.
*   **EPS Fluctuation:** EPS shows fluctuation which suggest an uncertain or evolving business landscape

**6. Financial Information**

**Revenue and Profitability**

| Quarter    | Revenue   | Profit Margin |
| ---------- | --------- | ------------- |
| 2025-03-31 | $15.53B   | 77.98%        |
| 2024-12-31 | $15.62B   | 75.50%        |
| 2024-09-30 | $16.66B   | 75.51%        |
| 2024-06-30 | $16.11B   | 76.76%        |
| 2024-03-31 | $15.78B   | 77.56%        |

**Capital and Profitability**

| Quarter    | Equity    | ROE     |
| ---------- | --------- | ------- |
| 2025-03-31 | $48.34B   | 10.51%  |
| 2024-12-31 | $46.31B   | 8.08%   |
| 2024-09-30 | $44.50B   | 7.09%   |
| 2024-06-30 | $43.58B   | 12.52%  |
| 2024-03-31 | $40.36B   | 11.80%  |

**Analysis:**

*   **Strong Profit Margins:** Profit margins are consistently high, indicating good cost control and pricing power.
*   **Growing Equity:** Equity has been generally increasing, suggesting a healthy balance sheet.
*   **Variable ROE:** ROE fluctuates, indicating variability in the company's ability to generate profit from shareholder equity.

**7. Overall Summary**

Merck & Co Inc (MRK) has significantly underperformed the S&P 500, and recent technical indicators point to a short-term downward trend. The company's financial data shows good profitability and a growing equity base, but recent news indicates volatility and the negative expected return is a significant concern and should be verified. Recent earnings and analyst discussions are likely driving the stock's movement. A cautious approach is warranted until the factors contributing to the underperformance and volatility are better understood.
